ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,590Medicare Part D Prescriptions Filled, Including Refills

Rank: 210 out of 2429

$518K Total Retail Price of All Prescriptions

Rank: 255 out of 2429

358 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 358 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 8,307 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 681 627 1 1
LEVOTHYROXINE SODIUM 499 387 2 3
OMEPRAZOLE 405 303 3 7
METOPROLOL TARTRATE 330 258 4 9
FUROSEMIDE 296 247 5 5
AMLODIPINE BESYLATE 286 258 6 4
HYDROCODONE-ACETAMINOPHEN 278 176 S3 7 6
CITALOPRAM HBR 240 212 8 19
WARFARIN SODIUM 239 236 9 11
METFORMIN HCL 224 198 10 8
ENALAPRIL MALEATE 208 156 11 32
METOPROLOL SUCCINATE 177 165 12 12
RISPERIDONE 161 43 13 52
ATORVASTATIN CALCIUM 152 113 14 13
METFORMIN HCL ER 147 93 15 65
LISINOPRIL 146 140 16 2
ZETIA 135 104 17 70
ZOLPIDEM TARTRATE 127 106 18 28
POTASSIUM CHLORIDE 123 98 19 14
CLOPIDOGREL 114 104 20 31
SERTRALINE HCL 104 78 21 23
TRAZODONE HCL 96 86 22 50
GABAPENTIN 94 74 23 18
ALLOPURINOL 93 72 24 33
HYDROCHLOROTHIAZIDE 86 71 25 10
ALENDRONATE SODIUM 86 62 25 20
DONEPEZIL HCL 86 86 25 26
RANITIDINE HCL 81 39 28 24
KLOR-CON 10 80 68 29 89
SINGULAIR 79 50 30 86
CARVEDILOL 78 78 31 21
GLIPIZIDE ER 77 60 32 72
TAMSULOSIN HCL 76 76 33 29
LOSARTAN POTASSIUM 70 57 34 22
BUSPIRONE HCL 69 62 35 160
TRAMADOL HCL 68 66 36 17
FENOFIBRATE 67 54 37 48
PLAVIX 67 64 37 44
GLIPIZIDE 65 53 39 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 54 40 27
PAROXETINE HCL 64 53 40 67
TRIAMTERENE-HCTZ 63 44 42 53
DIGOXIN 57 47 43 43
CRESTOR 56 56 44 25
BENICAR 55 55 45 164
ADVAIR DISKUS 55 55 45 49
PRAVASTATIN SODIUM 52 52 47 16
LOSARTAN-HYDROCHLOROTHIAZIDE 50 50 48 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.